Mark DeNichilo
Impact in
- Nephrology top 5%
- Chronic Kidney Disease and Diabetes
- Clinical Biochemistry top 5%
- Advanced Glycation End Products research
Papers in
-
- Connective Tissue Growth Factor Research 4
- Angiogenesis and VEGF in Cancer 4
- Bone Metabolism and Diseases 3
-
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 6
- Immune cells in cancer 3
- Co-authors
- Pedro Cortés (2 shared papers)Jerry Yee (2 shared papers)Bruce L. Riser (2 shared papers)Robert G. Narins (1 shared paper)Carrie E. Brubaker (1 shared paper)Shinong Wang (1 shared paper)Raimund Hirschberg (1 shared paper)Andreas Evdokiou (12 shared papers)
- Journals
- Molecular Oncology (2 papers)Cancer Medicine (2 papers)International Journal of Oncology (2 papers)Cancer Letters (2 papers)Kidney International (2 papers)
- Partner nations
- AustraliaUnited StatesSweden
In The Last Decade
Mark DeNichilo
24 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 94
- Nephrology 183
- Clinical Biochemistry 80
- Rehabilitation 71
- Molecular Biology 677
- Pathology and Forensic Medicine 170
Countries citing papers authored by Mark DeNichilo
This map shows the geographic impact of Mark DeNichilo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark DeNichilo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark DeNichilo more than expected).
Fields of papers citing papers by Mark DeNichilo
This network shows the impact of papers produced by Mark DeNichilo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark DeNichilo. The network helps show where Mark DeNichilo may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark DeNichilo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2000 | 341 | |
| 2 | 2001 | 179 | |
| 3 | 2001 | 104 | |
| 4 | 2008 | 101 | |
| 5 | 2003 | 79 | |
| 6 | 2017 | 49 | |
| 7 | 2014 | 41 | |
| 8 | 1991 | 33 | |
| 9 | 2015 | 32 | |
| 10 | 2015 | 28 | |
| 11 | 2016 | 26 | |
| 12 | 2021 | 24 | |
| 13 | 2016 | 22 | |
| 14 | 2014 | 19 | |
| 15 | 2016 | 16 | |
| 16 | 2015 | 15 | |
| 17 | 2021 | 11 | |
| 18 | 2009 | 11 | |
| 19 | 2017 | 8 | |
| 20 | Doxorubicin overcomes resistance to drozitumab by antagonizing Inhibitor of Apoptosis Proteins (IAPs). | 2014 | 8 |
About Mark DeNichilo
Mark DeNichilo is a scholar working on Molecular Biology, Immunology, Cancer Research, Immunology and Allergy and Pathology and Forensic Medicine, having authored 25 papers that have together received 1.2k indexed citations. Recurring topics across this work include Neutrophil, Myeloperoxidase and Oxidative Mechanisms (6 papers), Cell Adhesion Molecules Research (5 papers), Connective Tissue Growth Factor Research (4 papers), Angiogenesis and VEGF in Cancer (4 papers), Systemic Sclerosis and Related Diseases (3 papers), Cancer, Hypoxia, and Metabolism (3 papers), Bone Metabolism and Diseases (3 papers) and Immune cells in cancer (3 papers). The work is most often cited by research in Nephrology (183 citations), Clinical Biochemistry (80 citations), Rehabilitation (71 citations), Molecular Biology (677 citations) and Pathology and Forensic Medicine (170 citations). Mark DeNichilo has collaborated with scholars based in Australia, United States and Sweden. Frequent co-authors include Pedro Cortés, Jerry Yee, Bruce L. Riser, Robert G. Narins, Carrie E. Brubaker, Shinong Wang, Raimund Hirschberg, Andreas Evdokiou, Vasilios Panagopoulos and Vasilios Liapis. Their work appears in journals such as Molecular Oncology, Cancer Medicine, International Journal of Oncology, Cancer Letters and Kidney International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.